Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03946358
Title Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Hospitalier Universitaire de Besancon

vulva squamous cell carcinoma

anal squamous cell carcinoma

cervical squamous cell carcinoma

head and neck squamous cell carcinoma


Atezolizumab + UCPVax

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST